LAG-3 (humain): FC (humain ),, recombinant, exprimé en cellules CHO, > 99 %( SDS -PAGE)

Code: srp8040-50ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

LAG3 (lymphocyte activation gene 3) is a negative regulator of T-cell proliferation where it suppresses T-cell receptor (TCR)-mediated calcium fluxes ...


en savoir plus

Votre prix
$631.94 50UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

LAG3 (lymphocyte activation gene 3) is a negative regulator of T-cell proliferation where it suppresses T-cell receptor (TCR)-mediated calcium fluxes and modulates the memory T-cell pool size. It is a CD4 (cluster of differentiation) homolog that functions as a ligand for MHC (major histocompatibility complex) II. Membrane expression of LAG3 modulates the suppressive function of Tregs (T-regulatory) both in vivo and in vitro. HIV-1 (human immunodeficiency virus) infection results in significant increase in LAG3 peripheral blood and lymph node expression, which is exhibited on both CD4+ and CD8+ T cells, and this is linked with disease progression. In melanoma, this protein is responsible for TLR (Toll-like receptor)-independent activation of plasmacytoid dendritic cells (pDCs) at tumor sites, which is partially implicated in driving an immune-suppressive environment.

General description

LAG3 (lymphocyte activation gene 3) is an inhibitory CD4 (cluster of differentiation)-related molecule, and is expressed by activated CD4+ and CD8+ T cells.

Other Notes

The sequence coding for the 4 extracellular Ig-like domains of human LAG-3 (D1-D4) is fused to the Fc portion of human IgG1.

Physical form

Solution in PBS.

assay>99% (SDS-PAGE)
biological sourcehuman
colorclear
concentration≥0.2 mg/mL
formliquid
Gene Informationhuman ... LAG3(3902)
impurities﹤0.1 EU/µg endotoxin, tested
mol wt~80 kDa by SDS-PAGE
packagingpkg of 50 µg
recombinantexpressed in CHO cells
shipped inwet ice
storage temp.−20°C
UniProt accession no.P18627
Ce produit répond aux critères suivants: